← Back to Search
Determination Of Drug Release Kinetics From Nanoparticles: Overcoming Pitfalls Of The Dynamic Dialysis Method.
Sweta Modi, B. D. Anderson
Published 2013 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Dynamic dialysis is one of the most common methods for the determination of release kinetics from nanoparticle drug delivery systems. Drug appearance in the "sink" receiver compartment is a consequence of release from the nanoparticles into the dialysis chamber followed by diffusion across the dialysis membrane. This dual barrier nature inherent in the method complicates data interpretation and may lead to incorrect conclusions regarding nanoparticle release half-lives. Although the need to consider the barrier properties of the dialysis membrane has long been recognized, there is insufficient quantitative appreciation for the role of the driving force for drug transport across that membrane. Reversible nanocarrier binding of the released drug reduces the driving force for drug transport across the dialysis membrane leading to a slower overall apparent release rate. This may lead to the conclusion that a given nanoparticle system will provide a sustained release in vivo when it will not. This study demonstrates these phenomena using model lipophilic drug-loaded liposomes varying in lipid composition to provide variations in bilayer permeability and membrane binding affinities. Model simulations of liposomal transport as measured by dynamic dialysis were conducted to illustrate the interplay between the liposome concentration, membrane/water partition coefficient, and the apparent release rate. Reliable determination of intrinsic liposomal bilayer permeability coefficients for lipophilic drugs by dynamic dialysis requires validation of drug release kinetics at varying nanoparticle concentration and the determination of membrane binding coefficients along with appropriate mechanism-based mathematical modeling to ensure the reliability and proper interpretation of the data.
This paper references
Recent developments in lipid-based pharmaceutical nanocarriers.
T. Musacchio (2011)
Evaluation of dialysis membrane process for quantifying the in vitro drug-release from colloidal drug carriers
Gabriel Moreno-Bautista (2011)
Determination of intraliposomal pH and its effect on membrane partitioning and passive loading of a hydrophobic camptothecin, DB-67.
Vijay Joguparthi (2008)
Drug release from nanomedicines: selection of appropriate encapsulation and release methodology
S. J. Wallace (2012)
Lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate.
B. D. Kurmi (2011)
Dynamic dialysis as a method for studying protein binding. II. Evaluation of the method with a number of binding systems.
M. Meyer (1970)
Drug release from microdisperse systems: a critical review
C. Washington (1990)
Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations.
M. J. W. Johnston (2006)
The interaction of cationic dendrons with albumin and their diffusion through cellulose membranes.
G. Purohit (2003)
The Barrier Domain for Solute Permeation Varies With Lipid Bilayer Phase Structure
T. Xiang (1998)
Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions.
Sweta Modi (2012)
Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
M. R. Aji Alex (2011)
Dynamic dialysis as a method for studying protein binding. I. Factors affecting the kinetics of dialysis through a cellophane membrane.
M. Meyer (1970)
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.
H. Maeda (2013)
Tumor delivery of macromolecular drugs based on the EPR effect.
V. Torchilin (2011)
Modeling the Release Kinetics of Poorly Water-Soluble Drug Molecules from Liposomal Nanocarriers
S. Loew (2011)
Is dialysis a reliable method for studying drug release from nanoparticulate systems?-A case study.
Y. Zambito (2012)
Nanoparticles in Medicine: Therapeutic Applications and Developments
L. Zhang (2008)
Evaluation of non-sink dialysis methods for the measurement of drug release from colloids: effects of drug partition
C. Washington (1989)
Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles
J. Wang (2011)
Liposome transport of hydrophobic drugs: gel phase lipid bilayer permeability and partitioning of the lactone form of a hydrophobic camptothecin, DB-67.
Vijay Joguparthi (2008)
Stable Supersaturated Aqueous Solutions of Silatecan 7-t-Butyldimethylsilyl-10-Hydroxycamptothecin via Chemical Conversion in the Presence of a Chemically Modified β-Cyclodextrin
Tian-xiang Xiang (2004)
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model
M. Y. Levy (1990)
Active targeting schemes for nanoparticle systems in cancer therapeutics.
J. D. Byrne (2008)
Development of a combined NMR paramagnetic ion-induced line-broadening/dynamic light scattering method for permeability measurements across lipid bilayer membranes.
T. X. Xiang (1995)
Doxil® — The First FDA-Approved Nano- Drug: From an Idea to a Product
Y. Barenholz (2011)
In vitro evaluation of drug release kinetics from liposomes by fractional dialysis
Ingrid Henriksen (1995)
Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
S. Essa (2011)
Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
L. Mei (2013)
Quantitation of the release of doxorubicin from colloidal dosage forms using dynamic dialysis.
P. Gupta (1987)
Drug targeting strategies in cancer treatment: an overview.
J. L. Arias (2011)
Permeability of lipid bilayers to amino acids and phosphate.
A. C. Chakrabarti (1992)
A Mathematical Morel for Drug Release from 0/W Emulsions: Application to Controlled Release Morphine Emulsions
D. Friedman (1987)
Development and characterization of a novel liposome-based formulation of SN-38.
J. Zhang (2004)
Hydroxypropyl-β-cyclodextrin copolymers and their nanoparticles as doxorubicin delivery system.
Tiewei Wang (2011)
Nanomaterials for (Nano)medicine.
S. Marchesan (2013)
Liposomal drug delivery: thermodynamic and chemical kinetic considerations
R. Margalit (1991)
Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy.
D. Drummond (2006)
Permeability of acetic acid across gel and liquid-crystalline lipid bilayers conforms to free-surface-area theory.
T. X. Xiang (1997)
Bilayer Composition, Temperature, Speciation Effects and the Role of Bilayer Chain Ordering on Partitioning of Dexamethasone and its 21-Phosphate
Sweta Modi (2013)
Developments in liposomal drug delivery systems
N. Maurer (2001)
Modeling Drug-Carrier Interaction in the Drug Release from Nanocarriers
L. Zeng (2011)
Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.
Vijay Joguparthi (2008)
Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: characterization, in-vitro and in-vivo study.
R. C. Nagarwal (2011)
This paper is referenced by
Glutamate-Leucine Block Copolypeptides for Drug Delivery
B. S. Lee (2014)
POLYMER MICELLES FOR TUNABLE DRUG RELEASE AND ENHANCED ANTITUMOR EFFICACY
Andrei Ponta (2013)
Insights into accelerated liposomal release of topotecan in plasma monitored by a non-invasive fluorescence spectroscopic method.
Kyle D. Fugit (2015)
Design, Evaluation And Antimicrobial Activity Of Egyptian Propolis-Loaded Nanoparticles: Intrinsic Role As A Novel And Naturally Based Root Canal Nanosealer
Islam Ali Abdel Raheem (2019)
Analyzing drug load and release from pharmaceutical nanocarriers for the treatment of inflammatory bowel diseases
A. Guillot (2014)
Breast intraductal nanoformulations for treating ductal carcinoma in situ I: Exploring metal-ion complexation to slow ciclopirox release, enhance mammary persistence and efficacy.
Firas Al‐Zubaydi (2020)
sN 38-loaded , 100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity : in vitro and in vivo study
Yi-Ping Fang (2018)
Model for Microcapsule Drug Release with Ultrasound-Activated Enhancement.
Nadia H Tsao (2017)
Polymer nanoassemblies with solvato- and halo-fluorochromism for drug release monitoring and metastasis imaging.
Derek Reichel (2015)
Development of Afatinib lipid nanoparticles targeting non small cell lung cancer
A. Almurshedi (2018)
Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles.
J. Zaloga (2018)
Encapsulation of Zn-DTPA into poly lactic-co-glycolic acid nanoparticles via a modified double emulsion method for extended release into lung fluid 1
E. Lai (2018)
Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right?
Sara A Abouelmagd (2015)
Current Applications of Nanoemulsions in Cancer Therapeutics
E. Sánchez-López (2019)
IMPROVEMENT OF EFFICACY AND SAFETY PROFILE OF SIMVASTATIN IN COMPARISON TO REFERENCE PRODUCT (ZOCOR TABLETS) USING NANOPARTICULATE FORMULATION APPROACH
D. Gupta (2016)
Insights into particle formation and analysis
Jenni Pessi (2017)
Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model.
A. Hafner (2015)
Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting.
J. Zaloga (2016)
Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
Carl Simonsson (2016)
Early Development Challenges for Drug Products Containing Nanomaterials
Jennifer H. Grossman (2016)
Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
K. Thanki (2019)
Nanoparticles as drug carriers: current issues with in vitro testing.
Maryam A Shetab Boushehri (2015)
Solid Phase Extraction as an Innovative Separation Method for Measuring Free and Entrapped Drug in Lipid Nanoparticles
A. Guillot (2015)
Real-Time Drug Release Analysis of Enzyme and pH Responsive Polysaccharide Nanovesicles.
P. S. Pramod (2015)
Effect of tocopherol on the properties of Pluronic F127 microemulsions: Physico-chemical characterization and in vivo toxicity
Addas Rahdar (2019)
Visualisation photofragmentation induced Rhodamine B release from gold nanorod delivery system by combination two-photon luminescence imaging with correlation spectroscopy.
Shiqing Dong (2020)
One-pot polyglycidol nanogels via liposome master templates for dual drug delivery.
Jacob N Lockhart (2016)
Ignoring the modeling approaches: Towards the shadowy paths in nanomedicine
P. Hassanzadeh (2018)
Chitosan-decorated polystyrene-b-poly(acrylic acid) polymersomes as novel carriers for topical delivery of finasteride.
Thiago Caon (2014)
QUANTIFICATION OF FACTORS GOVERNING DRUG RELEASE KINETICS FROM NANOPARTICLES: A COMBINED EXPERIMENTAL AND MECHANISTIC MODELING APPROACH
Kyle D. Fugit (2014)
Nanoemulsions in Translational Research—Opportunities and Challenges in Targeted Cancer Therapy
Srinivas Ganta (2014)
Product quality for nanomaterials: current U.S. experience and perspective.
K. Tyner (2015)See more